These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28687457)

  • 61. Synthesis and anti-protozoal activity of novel dihydropyrrolo[3,4-d][1,2,3]triazoles.
    Dürüst Y; Karakuş H; Kaiser M; Tasdemir D
    Eur J Med Chem; 2012 Feb; 48():296-304. PubMed ID: 22217867
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Synthesis and bioassay of aminosulfonyl-1,3,4-oxadiazoles and their interconversion to 1,3,4-thiadiazoles.
    Padmavathi V; Reddy SN; Reddy GD; Padmaja A
    Eur J Med Chem; 2010 Sep; 45(9):4246-51. PubMed ID: 20630628
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Organocatalytic, enantioselective synthesis of VNI: a robust therapeutic development platform for Chagas, a neglected tropical disease.
    Dobish MC; Villalta F; Waterman MR; Lepesheva GI; Johnston JN
    Org Lett; 2012 Dec; 14(24):6322-5. PubMed ID: 23214987
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Synthesis of antimicrobial 2,9,10-trisubstituted-6-oxo-7,12-dihydro-chromeno[3,4-b]quinoxalines.
    Kotharkar SA; Shinde DB
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6181-4. PubMed ID: 17027265
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In vitro antitubercular and antimicrobial activities of 1-substituted quinoxaline-2,3(1H,4H)-diones.
    Ramalingam P; Ganapaty S; Rao ChB
    Bioorg Med Chem Lett; 2010 Jan; 20(1):406-8. PubMed ID: 19962890
    [TBL] [Abstract][Full Text] [Related]  

  • 66. 5-(5-Aryl-1,3,4-oxadiazole-2-carbonyl)furan-3-carboxylate and new cyclic C-glycoside analogues from carbohydrate precursors with MAO-B, antimicrobial and antifungal activities.
    El-Sadek MM; Hassan SY; El-Dayem NS; Yacout GA
    Molecules; 2012 Jun; 17(6):7010-27. PubMed ID: 22678415
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Synthesis and antibacterial activity of some novel bis-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and bis-4-thiazolidinone derivatives from terephthalic dihydrazide.
    Palekar VS; Damle AJ; Shukla SR
    Eur J Med Chem; 2009 Dec; 44(12):5112-6. PubMed ID: 19683841
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Design, synthesis and biological evaluation of hybrid bioisoster derivatives of N-acylhydrazone and furoxan groups with potential and selective anti-Trypanosoma cruzi activity.
    Massarico Serafim RA; Gonçalves JE; de Souza FP; de Melo Loureiro AP; Storpirtis S; Krogh R; Andricopulo AD; Dias LC; Ferreira EI
    Eur J Med Chem; 2014 Jul; 82():418-25. PubMed ID: 24929292
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Design, synthesis, and biological evaluation of 1,2,3-trisubstituted-1,4-dihydrobenzo[g]quinoxaline-5,10-diones and related compounds as antifungal and antibacterial agents.
    Tandon VK; Yadav DB; Maurya HK; Chaturvedi AK; Shukla PK
    Bioorg Med Chem; 2006 Sep; 14(17):6120-6. PubMed ID: 16806945
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Preparation and biological evaluation of 6/7-trifluoromethyl(nitro)-, 6,7-difluoro-3-alkyl (aryl)-substituted-quinoxalin-2-ones. Part 3.
    Sanna P; Carta A; Loriga M; Zanetti S; Sechi L
    Farmaco; 1999 Mar; 54(3):169-77. PubMed ID: 10371030
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Design and Synthesis of New 1,3,4-Oxadiazole - Benzothiazole and Hydrazone Derivatives as Promising Chemotherapeutic Agents.
    Kaya B; Hussin W; Yurttaş L; Turan-Zitouni G; Gençer HK; Baysal M; Karaduman AB; Kaplancıklı ZA
    Drug Res (Stuttg); 2017 May; 67(5):275-282. PubMed ID: 28561221
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Synthesis and antibacterial activity of fused 1, 2, 4-triazolo[4, 3-a]quinoxaline and oxopyrimido[2', 1':5, 1]-1, 2, 4-triazolo[4, 3-a]quinoxaline derivatives.
    Nasr MN
    Arch Pharm (Weinheim); 2002 Aug; 335(8):389-94. PubMed ID: 12397623
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Designing and exploring active N'-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against three Trypanosoma cruzi strains more prevalent in Chagas disease patients.
    Palace-Berl F; Pasqualoto KF; Jorge SD; Zingales B; Zorzi RR; Silva MN; Ferreira AK; de Azevedo RA; Teixeira SF; Tavares LC
    Eur J Med Chem; 2015; 96():330-9. PubMed ID: 25899337
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Synthesis of novel sulfonamide-1,2,4-triazoles, 1,3,4-thiadiazoles and 1,3,4-oxadiazoles, as potential antibacterial and antifungal agents. Biological evaluation and conformational analysis studies.
    Zoumpoulakis P; Camoutsis Ch; Pairas G; Soković M; Glamočlija J; Potamitis C; Pitsas A
    Bioorg Med Chem; 2012 Feb; 20(4):1569-83. PubMed ID: 22264752
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Synthesis and evaluation of antioxidant and antibacterial activities of new substituted bis(1,3,4-oxadiazoles), 3,5-bis(substituted) pyrazoles and isoxazoles.
    Abdu Musad E; Mohamed R; Saeed BA; Vishwanath BS; Rai KM
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3536-40. PubMed ID: 21612921
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Synthesis, characterization, electrochemical and biological studies on some metal(II) Schiff base complexes containing quinoxaline moiety.
    Dhanaraj CJ; Johnson J
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Jan; 118():624-31. PubMed ID: 24095772
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Synthesis and antimicrobial evaluation of some new oxadiazoles derived from phenylpropionohydrazides.
    Fuloria NK; Singh V; Shaharyar M; Ali M
    Molecules; 2009 May; 14(5):1898-903. PubMed ID: 19471209
    [TBL] [Abstract][Full Text] [Related]  

  • 78. New 2-benzylsulfanyl-nicotinic acid based 1,3,4-oxadiazoles: their synthesis and biological evaluation.
    Patel NB; Purohit AC; Rajani DP; Moo-Puc R; Rivera G
    Eur J Med Chem; 2013 Apr; 62():677-87. PubMed ID: 23434641
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Synthesis and biological evaluation of quinones derived from natural product komaroviquinone as anti-Trypanosoma cruzi agents.
    Suto Y; Nakajima-Shimada J; Yamagiwa N; Onizuka Y; Iwasaki G
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2967-71. PubMed ID: 26037321
    [TBL] [Abstract][Full Text] [Related]  

  • 80. 3-Trifluoromethylquinoxaline N,N'-dioxides as anti-trypanosomatid agents. Identification of optimal anti-T. cruzi agents and mechanism of action studies.
    Benitez D; Cabrera M; Hernández P; Boiani L; Lavaggi ML; Di Maio R; Yaluff G; Serna E; Torres S; Ferreira ME; Vera de Bilbao N; Torres E; Pérez-Silanes S; Solano B; Moreno E; Aldana I; López de Ceráin A; Cerecetto H; González M; Monge A
    J Med Chem; 2011 May; 54(10):3624-36. PubMed ID: 21506600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.